Cargando…
Organoid technology demonstrates effects of potential drugs for COVID‐19 on the lung regeneration
Autores principales: | Wang, Jianhai, Li, Xue, Wang, An, Zhao, Fuxiaonan, Wu, Qi, Li, Li, Yu, Hongzhi, Wu, Junping, Chen, Huaiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645865/ https://www.ncbi.nlm.nih.gov/pubmed/33078494 http://dx.doi.org/10.1111/cpr.12928 |
Ejemplares similares
-
Organoid technology and lung injury mouse models evaluating effects of hydroxychloroquine on lung epithelial regeneration
por: Zhao, Fuxiaonan, et al.
Publicado: (2022) -
Impaired lung regeneration after SARS‐CoV‐2 infection
por: Shao, Hongxia, et al.
Publicado: (2020) -
Glutamine Metabolism Is Required for Alveolar Regeneration during Lung Injury
por: Wang, Sisi, et al.
Publicado: (2022) -
SARS-CoV-2 Infection and Lung Regeneration
por: Zhao, Fuxiaonan, et al.
Publicado: (2022) -
Niche-Dependent Regulation of Lkb1 in the Proliferation of Lung Epithelial Progenitor Cells
por: Ma, Qingwen, et al.
Publicado: (2022)